|
|
|
Telemedicine
Server |
| |
Lucid Previews
VivaNet(TM) Telemedicine Server For Dermatology Applications
Other Topics: Medical
Informatics Infection Control,
Nursing Informatics
Lucid, Inc.
February 22, 2007
Lucid, Inc. has previewed its VivaNet(TM) telemedicine server
for dermatology applications. The VivaNet(TM) server is intended
to link dermatology practitioners using Lucid's non- invasive
VivaScope(R) confocal imagers with other dermatologists or
pathologists via the Internet.
"Lucid's non-invasive VivaScope(R) confocal microscopes provide
cellular resolution images of skin that may be used by a
dermatologist to assist in forming a clinical judgment for a
variety of skin conditions," said Jay Eastman, Chairman and CEO
of Lucid, Inc. He continued, "VivaNet(TM) is intended to provide
fast, accurate, and secure storage, retrieval and transfer of
VivaScope(R) digital cellular resolution images across the
Internet to facilitate professional collaboration and
consultation." |
| |
|
|
| |
During a typical
VivaScope(R) imaging session, both dermatoscopic quality, full
color macroscopic pictures and microscopic, cellular resolution
images of the patient's skin are imaged. Once all of the images
for a single session are completed, the images and patient
related data are transferred for storage to the secure
VivaNet(TM) server and are immediately available for retrieval
by and transfer to other authorized practitioners for their
review and collaboration.
VivaNet(TM) is an Internet-based, DICOM-compliant application
that enables the transfer of VivaScope(R) digital images between
practitioners and pathologists for rapid review of confocal
images. DICOM, which is an acronym for Digital Imaging and
Communications in Medicine, is an internationally accepted, and
widely used open standard for the storage, retrieval and
transfer of medical images. HIPAA-compliance, privacy, and data
integrity are assured by using proven DICOM compliant software
modules that incorporate advanced encryption techniques.
"Our plan is that VivaNet(TM) will ultimately make in-vivo
confocal images available for review by other dermatologists and
pathologists in minutes, not days, thus enabling rapid,
real-time professional collaboration," said Eastman. "Lucid's
ultimate goal is that practitioners will rapidly receive a
pathologic interpretation of confocal images from a VivaScope(R)
session, potentially assisting the practitioner in arriving at a
clinical judgment while the patient is still in the doctor's
office."
Under a 3-year grant from the National Institute of Health's
National Cancer Institute, Lucid is conducting a five site
clinical study to determine the diagnostic accuracy of
VivaScope(R) images for pigmented lesions. Pilot studies of the
procedure, published in 2004 - 2006, demonstrated high
sensitivity and specificity for VivaScope images when read by a
panel of diagnostic readers with relatively little training in
confocal image interpretation (30 to 60 minutes). This study
will be facilitated by the use of the VivaNet(TM) server.
"We are excited to introduce VivaNet(TM) to the dermatology
community and believe that the combination of Lucid's patented
VivaScope(R) and VivaNet(TM) technologies, that enable near
real-time storage, retrieval and communication of in-vivo
confocal images, will ultimately bring these tools into routine
clinical use," said Eastman.
About Lucid, Inc.
Lucid Inc., based in Rochester, New York, is a medical device
and information company dedicated to creating innovative
cellular imaging technology and using the Internet to securely
deliver accurate, real-time VivaScope(R) cellular resolution
images to medical professionals. The Company's digital
VivaNet(TM) server, coupled with its ability to image in- vivo
(living) tissue is envisioned to ultimately aid medical
practitioners and pathologists in screening for skin cancer and
other dermatologic conditions with clarity, speed and patient
comfort. For more information, visit http://www.Lucid-tech.com. |
| |
|
|
| |
|
|
